Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases

Journal of Allergy and Clinical Immunology

Volumn 122, Issue 3, 2008, Pages 574-580

  Castells, Mariana C ^a   Tennant, Nichole M ^a   Sloane, David E ^a   Ida Hsu, F ^a   Barrett, Nora A ^a   Hong, David I ^a   Laidlaw, Tanya M ^a   Legere, Henry J ^a   Nallamshetty, Samridhi N ^a   Palis, Ross I ^a   Rao, Jayanti J ^a   Berlin, Suzanne T ^b   Campos, Susana M ^b   Matulonis, Ursula A ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

adverse drug reactions; Anaphylaxis; carboplatin; chemotherapy agents; hypersensitivity reactions; monoclonal antibodies; paclitaxel; rapid desensitization

Indexed keywords

CARBOPLATIN; CISPLATIN; DIPHENHYDRAMINE; DOXORUBICIN; FAMOTIDINE; LORAZEPAM; OXALIPLATIN; PACLITAXEL; RANITIDINE; RITUXIMAB;

ABDOMINAL PAIN; ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; BACKACHE; BLOATING; BREAST CANCER; CANCER CHEMOTHERAPY; COUGHING; DESENSITIZATION; DIARRHEA; DISORIENTATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; EAR DISEASE; FATTY ACID DESATURATION; FEMALE; FLUSHING; HALLUCINATION; HUMAN; HYPERTENSION; HYPOTENSION; INTENSIVE CARE UNIT; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; MALE; NAUSEA; NOSE CONGESTION; OVARY CANCER; PARESTHESIA; PERITONEUM CANCER; PRESYNCOPE; PRIORITY JOURNAL; PRURITUS; SIDE EFFECT; SKIN TEST; SNEEZING; SYNCOPE; TACHYCARDIA; TASTE DISCRIMINATION; TASTE DISORDER; THORAX PAIN; THROAT TIGHTNESS; URTICARIA; VISUAL DISORDER; VOMITING; WEAKNESS; WHEEZING;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CLINICAL PROTOCOLS; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MALE; MIDDLE AGED; SKIN TESTS; TREATMENT OUTCOME;

EID: 50649085243     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.02.044     Document Type: Article

References (24)

1. Markman M., Kennedy A., Webster K., Elson P., Peterson G., Kulp B., et al. Clinical features of hypersensitivity reactions to carboplatin. J Clin Oncol 17 (1999) 1141-1145
2. Dizon D.S., Sabbatini P.J., Aghajanian C., Hensley M.L., and Spriggs D.R. Analysis of patients with epithelial ovarian cancer or fallopian tube carcinoma retreated with cisplatin after the development of a carboplatin allergy. Gynecol Oncol 84 (2002) 378-382
3. Zweizig S., Roman L.D., and Muderspach L.I. Death from anaphylaxis to cisplatin: a case report. Gynecol Oncol 53 (1994) 121-122
4. Zanotti K.M., Rybicki L.A., Kennedy A.W., Belinson J.L., Webster K.D., Kulp B., et al. Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy. J Clin Oncol 19 (2001) 3126-3129
5. Markman M., Kennedy A., Webster K., Kulp B., Peterson G., and Belinson J. Paclitaxel-associated hypersensitivity reactions: experience of the gynecological oncology program of the Cleveland Clinic Cancer Center. J Clin Oncol 18 (2000) 102-105
6. Goldberg A., Confino-Cohen R., Fishman A., Beyth Y., and Altaras M. A modified, prolonged desensitization protocol in carboplatin allergy. J Allergy Clin Immunol 98 (1996) 841-843
7. Morales A.R., Shah N., and Castells M. Antigen-IgE desensitization in signal transducer and activator of transcription 6-deficient mast cells by suboptimal doses of antigen. Ann Allergy Asthma Immunol 94 (2005) 575-580
8. Feldweg A.M., Lee C.W., Matulonis U.A., and Castells M. Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments. Gynecol Oncol 96 (2005) 824-829
9. Lee C.W., Matulonis U.A., and Castells M.C. Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions. Gynecol Oncol 95 (2004) 370-376
10. Lee C.W., Matulonis U.A., and Castells M.C. Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: standard protocol effective in 57 patients for 255 courses. Gynecol Oncol 99 (2005) 393-399
11. Garufi C., Cristaudo A., Vanni B., Bria E., Aschelter A.M., Santucci B., et al. Skin testing and hypersensitivity reactions to oxaliplatin. Ann Oncol 14 (2003) 497-498
12. Markman M., Zanotti K., Peterson G., Kulp B., Webster K., and Belinson J. Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity. J Clin Oncol 21 (2003) 4611-4614
13. Weiss R.B., Donehower R.C., Wiernik P.H., Ohnuma T., Gralla R.J., Trump D.L., et al. Hypersensitivity reactions from taxol. J Clin Oncol 8 (1990) 1263-1268
14. Balsari A., Lombardo N., and Ghione M. Skin and perivascular toxicity induced experimentally by doxorubicin. J Chemother 1 (1989) 324-329
15. Choi J., Harnett P., and Fulcher D.A. Carboplatin desensitization. Ann Allergy Asthma Immunol 93 (2004) 137-141
16. Castells M. Drug desensitization in oncology: chemotherapy agents and moncolonal antibodies. In: Pichler W.J. (Ed). Drug hypersensitivity (2007), Karger, New York 413-425
17. Sheffer A.L., Feldweg A.M., and Castells M. Anaphylaxis. In: Holgate S.T., Church M.K., and Lichtenstein L.M. (Eds). Allergy (2006), Mosby Elsevier, London 167-178
18. Mullins D.W., Burger C.J., and Elgert K.D. Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide. J Immunol 162 (1999) 6811-6818
19. Perera P.Y., Mayadas T.N., Takeuchi O., Akira S., Zaks-Zilberman M., Goyert S.M., et al. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J Immunol 166 (2001) 574-581
20. Sykes E., Woodburn K., Decker D., and Kessel D. Effects of Cremophor EL on distribution of taxol to serum lipoproteins. Br J Cancer 70 (1994) 401-404
21. Wendel G.D., Stark B.J., Jamison R.B., Molina R.B., and Sullivan T.J. Penicillin allergy and desensitization in serious infections during pregnancy. N Engl J Med 312 (1985) 1229-1232
22. Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer 2006;354:34-43.
23. Sehn L.H., Donaldson J., Filewich A., Fitzgerald C., Gill K.K., Runzer N., et al. Rapid infusion rituximab in combination with corticosteroid-containing chemotherapy or as maintenance therapy is well tolerated and can safely be delivered in the community setting. Blood 109 (2007) 4171-4173
24. Rosique-Robles D., Vicent Verge J.M., Borras-Blasco J., Giner-Marco V., Castera E., Galan-Brotons A., et al. Successful desensitization protocol for hypersensitivity reactions caused by oxaliplatin. Int J Clin Pharmacol Ther 45 (2007) 606-610